TNDM Q3 2024 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$363M+95.7% YoY

Gross Profit

$125M34.3% margin

Operating Income

-$26M-7.2% margin

Net Income

-$23M-6.4% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+63.7%

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$22M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$958M

Total Liabilities

$720M

Stockholders' Equity

$238M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$363M	$186M	+95.7%
Gross Profit	$125M	$90M	+38.9%
Operating Income	-$26M	-$32M	+17.3%
Net Income	-$23M	-$33M	+29.5%

Revenue Segments

Supplies and Other

$128M53%

Pump

$115M47%

Geographic Segments

UNITED STATES

$172M70%

Non-US

$72M30%